{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T06:48:21Z","timestamp":1776235701940,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Model"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00894-026-06634-6","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T08:27:45Z","timestamp":1769588865000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["miRNAs mediated Hsa21 gene suppression as potential therapeutic agent for Down syndrome: molecular dynamics and MM\/PBSA-based study"],"prefix":"10.1007","volume":"32","author":[{"given":"Prashasti","family":"Sinha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil Kumar","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"6634_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0143-7","author":"SE Antonarakis","year":"2020","unstructured":"Antonarakis SE, Skotko BG, Rafii MS, Strydom A et al (2020) Down syndrome. Nat Rev Dis Primers. https:\/\/doi.org\/10.1038\/s41572-019-0143-7","journal-title":"Nat Rev Dis Primers"},{"key":"6634_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00439-009-0696-8","volume":"126","author":"D Patterson","year":"2009","unstructured":"Patterson D (2009) Molecular genetic analysis of Down syndrome. Hum Genet 126:195\u2013214. https:\/\/doi.org\/10.1007\/s00439-009-0696-8","journal-title":"Hum Genet"},{"key":"6634_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134861","author":"PV Belichenko","year":"2015","unstructured":"Belichenko PV, Kleschevnikov AM, Becker A et al (2015) Down syndrome cognitive phenotypes modeled in mice trisomic for all HSA 21 homologues. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0134861","journal-title":"PLoS One"},{"key":"6634_CR4","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1159\/000354306","volume":"141","author":"J Busciglio","year":"2013","unstructured":"Busciglio J, Capone G, O\u2019byran JP, Gardiner KJ (2013) Down syndrome: genes, model systems, and progress towards pharmacotherapies and clinical trials for cognitive deficits. Cytogenet Genome Res 141:260\u2013271. https:\/\/doi.org\/10.1159\/000354306","journal-title":"Cytogenet Genome Res"},{"key":"6634_CR5","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.18632\/aging.102677","volume":"12","author":"W Gomez","year":"2020","unstructured":"Gomez W, Morales R, Maracaja-Coutinho V, Parra V, Nassif M (2020) Down syndrome and Alzheimer\u2019s disease: common molecular traits beyond the amyloid precursor protein. Aging 12:1011. https:\/\/doi.org\/10.18632\/aging.102677","journal-title":"Aging"},{"key":"6634_CR6","doi-asserted-by":"publisher","DOI":"10.1080\/14728214.2025.2481847","author":"M Lozupone","year":"2025","unstructured":"Lozupone M, Dibello V, Daniele A, Panza F (2025) An update on emerging anti-amyloid-\u03b2 monoclonal antibodies for treating Alzheimer\u2019s disease: the role of apolipoprotein E. Expert Opin Emerg Drugs. https:\/\/doi.org\/10.1080\/14728214.2025.2481847","journal-title":"Expert Opin Emerg Drugs"},{"key":"6634_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70158","author":"L Maure-Blesa","year":"2025","unstructured":"Maure-Blesa L, Carmona-Iragui M, Lott I, Head E, Wisniewski T, Rafii MS, Fortea J (2025) The history of Down syndrome\u2013associated Alzheimer\u2019s disease; past, present, and future. Alzheimers Dement. https:\/\/doi.org\/10.1002\/alz.70158","journal-title":"Alzheimers Dement"},{"key":"6634_CR8","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1007\/s00018-009-0123-2","volume":"66","author":"J Park","year":"2009","unstructured":"Park J, Song WJ, Chung KC (2009) Function and regulation of Dyrk1A: towards understanding Down syndrome. Cell Mol Life Sci 66:3235\u20133240. https:\/\/doi.org\/10.1007\/s00018-009-0123-2","journal-title":"Cell Mol Life Sci"},{"key":"6634_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.pharmthera.2018.09.010","volume":"194","author":"ML Arbones","year":"2019","unstructured":"Arbones ML, Thomazeau A, Nakano-Kobayashi A, Hagiwara M, Delabar JM (2019) DYRK1A and cognition: a lifelong relationship. Pharmacol Ther 194:199\u2013221. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.09.010","journal-title":"Pharmacol Ther"},{"key":"6634_CR10","doi-asserted-by":"publisher","first-page":"11049","DOI":"10.1073\/pnas.96.20.11049","volume":"96","author":"S Sinha","year":"1999","unstructured":"Sinha S, Lieberburg I (1999) Cellular mechanisms of \u03b2-amyloid production and secretion. Proc Natl Acad Sci U S A 96:11049\u201311053. https:\/\/doi.org\/10.1073\/pnas.96.20.11049","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6634_CR11","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1007\/s00277-023-05447-4","volume":"102","author":"T Vall\u00e9e","year":"2023","unstructured":"Vall\u00e9e T, Schmid I, Gloning L, Bacova M et al (2023) Excellent outcome of stem cell transplantation for sickle cell disease. Ann Hematol 102:3217\u20133227. https:\/\/doi.org\/10.1007\/s00277-023-05447-4","journal-title":"Ann Hematol"},{"key":"6634_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/B978-0-444-54299-1.00012-1","volume":"197","author":"C Fillat","year":"2012","unstructured":"Fillat C, Altafaj X (2012) Gene therapy for Down syndrome. Prog Brain Res 197:237\u2013247. https:\/\/doi.org\/10.1016\/B978-0-444-54299-1.00012-1","journal-title":"Prog Brain Res"},{"key":"6634_CR13","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1007\/s12035-021-02638-w","volume":"59","author":"L Guan","year":"2022","unstructured":"Guan L, Han Y, Yang C, Lu S et al (2022) CRISPR-Cas9-mediated gene therapy in neurological disorders. Mol Neurobiol 59:968\u2013982. https:\/\/doi.org\/10.1007\/s12035-021-02638-w","journal-title":"Mol Neurobiol"},{"key":"6634_CR14","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1016\/j.ymthe.2021.05.023","volume":"29","author":"M Parrini","year":"2021","unstructured":"Parrini M, Naskar S, Alberti M, Colombi I et al (2021) Restoring neuronal chloride homeostasis with anti-NKCC1 gene therapy rescues cognitive deficits in a mouse model of Down syndrome. Mol Ther 29:3072\u20133092. https:\/\/doi.org\/10.1016\/j.ymthe.2021.05.023","journal-title":"Mol Ther"},{"key":"6634_CR15","first-page":"125","volume":"5","author":"M Kazemi","year":"2016","unstructured":"Kazemi M, Salehi M, Kheirollahi M (2016) Down syndrome: current status, challenges and future perspectives. Int J Mol Cell Med 5:125\u2013133","journal-title":"Int J Mol Cell Med"},{"key":"6634_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.592571","author":"PK Wong","year":"2021","unstructured":"Wong PK, Cheah FC, Syafruddin SE et al (2021) CRISPR gene-editing models geared toward therapy for hereditary and developmental neurological disorders. Front Pediatr. https:\/\/doi.org\/10.3389\/fped.2021.592571","journal-title":"Front Pediatr"},{"key":"6634_CR17","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.molmed.2006.08.005","volume":"12","author":"SE Antonarakis","year":"2006","unstructured":"Antonarakis SE, Epstein CJ (2006) The challenge of Down syndrome. Trends Mol Med 12:473\u2013479. https:\/\/doi.org\/10.1016\/j.molmed.2006.08.005","journal-title":"Trends Mol Med"},{"key":"6634_CR18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrg.2016.154","volume":"18","author":"SE Antonarakis","year":"2017","unstructured":"Antonarakis SE (2017) Down syndrome and the complexity of genome dosage imbalance. Nat Rev Genet 18:147\u2013163. https:\/\/doi.org\/10.1038\/nrg.2016.154","journal-title":"Nat Rev Genet"},{"key":"6634_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/dgd.12107","volume":"56","author":"H Lisa Li","year":"2014","unstructured":"Lisa Li H, Nakano T, Hotta A (2014) Genetic correction using engineered nucleases for gene therapy applications. Dev Growth Differ 56:63\u201377. https:\/\/doi.org\/10.1111\/dgd.12107","journal-title":"Dev Growth Differ"},{"key":"6634_CR20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3390\/cells9010239","volume":"9","author":"SN Akutsu","year":"2020","unstructured":"Akutsu SN, Fujita K, Tomioka K, Miyamoto T, Matsuura S (2020) Applications of genome editing technology in research on chromosome aneuploidy disorders. Cells 9:239. https:\/\/doi.org\/10.3390\/cells9010239","journal-title":"Cells"},{"key":"6634_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/9781118131411","volume-title":"Computational approaches in cheminformatics and bioinformatics","author":"R Guha","year":"2011","unstructured":"Guha R, Bender A (2011) Computational approaches in cheminformatics and bioinformatics. John Wiley and Sons"},{"key":"6634_CR22","doi-asserted-by":"crossref","unstructured":"Lim HA (1996) Bioinformatics and cheminformatics in the drug discovery cycle. German Conference on Bioinformatics. Springer Berlin Heidelberg, Berlin, Heidelberg, pp 30\u201343","DOI":"10.1007\/BFb0033201"},{"key":"6634_CR23","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1093\/bib\/bby054","volume":"20","author":"L Chen","year":"2019","unstructured":"Chen L, Heikkinen L, Wang C, Yang Y, Sun H, Wong G (2019) Trends in the development of mirna bioinformatics tools. Briefings Bioinf 20:1836\u20131852. https:\/\/doi.org\/10.1093\/bib\/bby054","journal-title":"Briefings Bioinf"},{"key":"6634_CR24","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1089\/hum.2024.113","volume":"35","author":"S Brillante","year":"2024","unstructured":"Brillante S, Volpe M, Indrieri A (2024) Advances in microrna therapeutics: from preclinical to clinical studies. Hum Gene Ther 35:628\u2013648. https:\/\/doi.org\/10.1089\/hum.2024.113","journal-title":"Hum Gene Ther"},{"key":"6634_CR25","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2147\/DDDT.S288859","volume":"15","author":"S Zhang","year":"2021","unstructured":"Zhang S, Cheng Z, Wang Y, Han T (2021) The risks of mirna therapeutics: in a drug target perspective. Drug Des Devel Ther 15:721\u2013733. https:\/\/doi.org\/10.2147\/DDDT.S288859","journal-title":"Drug Des Devel Ther"},{"key":"6634_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/genes12111833","author":"H Atas-Ozcan","year":"2021","unstructured":"Atas-Ozcan H, Brault V, Duchon A, Herault Y (2021) Dyrk1a from gene function in development and physiology to dosage correction across life span in down syndrome. Genes. https:\/\/doi.org\/10.3390\/genes12111833","journal-title":"Genes"},{"key":"6634_CR27","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen Y, Wang X (2020) miRDB: an online database for prediction of functional microrna targets. Nucleic Acids Res 48:D127\u2013D131. https:\/\/doi.org\/10.1093\/nar\/gkz757","journal-title":"Nucleic Acids Res"},{"key":"6634_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206239","author":"C Sticht","year":"2018","unstructured":"Sticht C, De La Torre C, Parveen A, Gretz N (2018) miRWalk: an online resource for prediction of microrna binding sites. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0206239","journal-title":"PLoS One"},{"key":"6634_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13235913","author":"D Misiak","year":"2021","unstructured":"Misiak D, Bauer M, Lange J, Haase J, Braun J, Lorenz K, Wickenhauser C, H\u00fcttelmaier S (2021) MiRNA deregulation distinguishes anaplastic thyroid carcinoma (ATC) and supports upregulation of oncogene expression. Cancers. https:\/\/doi.org\/10.3390\/cancers13235913","journal-title":"Cancers"},{"key":"6634_CR30","doi-asserted-by":"publisher","first-page":"W451","DOI":"10.1093\/nar\/gkl243","volume":"34","author":"J Kr\u00fcger","year":"2006","unstructured":"Kr\u00fcger J, Rehmsmeier M (2006) RNAhybrid: microrna target prediction easy, fast and flexible. Nucleic Acids Res 34:W451\u2013W454. https:\/\/doi.org\/10.1093\/nar\/gkl243","journal-title":"Nucleic Acids Res"},{"key":"6634_CR31","doi-asserted-by":"publisher","first-page":"W435","DOI":"10.1093\/nar\/gkx279","volume":"45","author":"M Mann","year":"2017","unstructured":"Mann M, Wright PR, Backofen R (2017) IntaRNA 2.0: enhanced and customizable prediction of RNA\u2013RNA interactions. Nucleic Acids Res 45:W435\u2013W439. https:\/\/doi.org\/10.1093\/nar\/gkx279","journal-title":"Nucleic Acids Res"},{"key":"6634_CR32","doi-asserted-by":"crossref","unstructured":"Gruber AR, Bernhart SH, Lorenz R (2015) The ViennaRNA web services. RNA bioinformatics, Springer pp 307\u201326","DOI":"10.1007\/978-1-4939-2291-8_19"},{"key":"6634_CR33","doi-asserted-by":"crossref","unstructured":"Biesiada M, Purzycka KJ, Szachniuk M, Blazewicz J, Adamiak RW (2016) Automated RNA 3D structure prediction with RNAComposer. RNA structure determination: methods and protocols, New York, Springer pp 199\u2013215","DOI":"10.1007\/978-1-4939-6433-8_13"},{"key":"6634_CR34","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1093\/nar\/gkl412","volume":"34","author":"M van Dijk","year":"2006","unstructured":"van Dijk M, van Dijk AD, Hsu V, Boelens R, Bonvin AM (2006) Information-driven protein\u2013DNA docking using HADDOCK: it is a matter of flexibility. Nucleic Acids Res 34:3317\u20133325. https:\/\/doi.org\/10.1093\/nar\/gkl412","journal-title":"Nucleic Acids Res"},{"key":"6634_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-42990-5","author":"SE Guard","year":"2019","unstructured":"Guard SE, Poss ZC, Ebmeier CC, Pagratis M, Simpson H, Taatjes DJ, Old WM (2019) The nuclear interactome of DYRK1A reveals a functional role in DNA damage repair. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-019-42990-5","journal-title":"Sci Rep"},{"key":"6634_CR36","unstructured":"Biovia DS, Berman HM, Westbrook J, Feng Z, et al (2000) Dassault syst\u00e8mes BIOVIA, discovery studio visualizer, v. 17.2, San Diego, Dassault Syst\u00e8mes 2016 J Chem Phys 10:21\u20139991"},{"key":"6634_CR37","unstructured":"Bauer P, Hess B, Lindahl E (2022) GROMACS 2022.1 Manual Zenodo 1:673"},{"key":"6634_CR38","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","volume":"16","author":"C Tian","year":"2019","unstructured":"Tian C, Kasavajhala K, Belfon KA, Raguette L et al (2019) Ff19SB: amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution. J Chem Theory Comput 16:528\u2013552","journal-title":"J Chem Theory Comput"},{"key":"6634_CR39","doi-asserted-by":"publisher","DOI":"10.1063\/5.0249905","volume":"162","author":"AK Das","year":"2025","unstructured":"Das AK, Tuckerman ME, Kirmizialtin S (2025) Hb-cufix: force field for accurate RNA simulations. J Chem Phys 162. https:\/\/doi.org\/10.1063\/5.0249905","journal-title":"J Chem Phys"},{"key":"6634_CR40","unstructured":"Swails J, Hernandez C, Mobley DL, Nguyen H, Wang LP, Janowski P (2010) ParmEd https:\/\/github.com\/ParmEd\/ParmEd"},{"key":"6634_CR41","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen WL, Chandrasekhar J, Madura JD et al (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79:926\u2013935. https:\/\/doi.org\/10.1063\/1.445869","journal-title":"J Chem Phys"},{"key":"6634_CR42","doi-asserted-by":"publisher","first-page":"7182","DOI":"10.1063\/1.328693","volume":"52","author":"M Parrinello","year":"1981","unstructured":"Parrinello M, Rahman A (1981) Polymorphic transitions in single crystals: a new molecular dynamics method. J Appl Phys 52:7182\u20137190. https:\/\/doi.org\/10.1063\/1.328693","journal-title":"J Appl Phys"},{"key":"6634_CR43","doi-asserted-by":"crossref","unstructured":"Roe DR, Cheatham TE III (2013) Ptraj and cpptraj: software for processing and analysis of molecular dynamics trajectory data. J Chem Theory Comput 9:3084\u20133095","DOI":"10.1021\/ct400341p"},{"key":"6634_CR44","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","volume":"17","author":"MS Vald\u00e9s-Tresanco","year":"2021","unstructured":"Vald\u00e9s-Tresanco MS, Vald\u00e9s-Tresanco ME, Valiente PA, Moreno E (2021) Gmx_mmpbsa: a new tool to perform end-state free energy calculations with GROMACS. J Chem Theory Comput 17:6281\u20136291","journal-title":"J Chem Theory Comput"},{"key":"6634_CR45","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1038\/ncb2126","volume":"12","author":"PA da Costa Martins","year":"2010","unstructured":"da Costa Martins PA, Salic K, Gladka MM, Armand AS et al (2010) MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin\/NFAT signalling. Nat Cell Biol 12:1220\u20131227. https:\/\/doi.org\/10.1038\/ncb2126","journal-title":"Nat Cell Biol"},{"key":"6634_CR46","doi-asserted-by":"publisher","first-page":"13036","DOI":"10.18632\/oncotarget.24437","volume":"9","author":"S Pagotto","year":"2018","unstructured":"Pagotto S, Veronese A, Soranno A et al (2018) Hsa-miR-155-5p drives aneuploidy at early stages of cellular transformation. Oncotarget 9:13036. https:\/\/doi.org\/10.18632\/oncotarget.24437","journal-title":"Oncotarget"},{"key":"6634_CR47","doi-asserted-by":"publisher","unstructured":"Morris GM, Lim-Wilby M (2008) Molecular docking Molecular modeling of proteins. <book-title update=\"added\">Molecular Modeling of Proteins, vol 443. pp 365\u2013382. https:\/\/doi.org\/10.1007\/978-1-59745-177-2_19","DOI":"10.1007\/978-1-59745-177-2_19"},{"key":"6634_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012029","author":"R Patil","year":"2010","unstructured":"Patil R, Das S, Stanley A, Yadav L (2010) Optimized hydrophobic interactions and hydrogen bonding at the target-ligand interface leads the pathways of drug-designing. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0012029","journal-title":"PLoS One"},{"key":"6634_CR49","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S0959-440X(02)00308-1","volume":"12","author":"T Hansson","year":"2002","unstructured":"Hansson T, Oostenbrink C, van Gunsteren W (2002) Molecular dynamics simulations. Curr Opin Struct Biol 12:190\u2013196. https:\/\/doi.org\/10.1016\/S0959-440X(02)00308-1","journal-title":"Curr Opin Struct Biol"},{"key":"6634_CR50","doi-asserted-by":"publisher","first-page":"6596","DOI":"10.1021\/jm0608210","volume":"49","author":"A Weis","year":"2006","unstructured":"Weis A, Katebzadeh K, S\u00f6derhjelm P, Nilsson I, Ryde U (2006) Ligand affinities predicted with the MM\/PBSA method: dependence on the simulation method and the force field. J Med Chem 49:6596\u20136606","journal-title":"J Med Chem"},{"key":"6634_CR51","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1021\/ja994180s","volume":"122","author":"B Kuhn","year":"2000","unstructured":"Kuhn B, Kollman PA (2000) A ligand that is predicted to bind better to avidin than biotin: insights from computational fluorine scanning. J Am Chem Soc 122:3909\u20133916","journal-title":"J Am Chem Soc"},{"key":"6634_CR52","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.1021\/acs.jctc.9b00649","volume":"15","author":"AW Duster","year":"2019","unstructured":"Duster AW, Lin H (2019) Tracking proton transfer through titratable amino acid side chains in adaptive QM\/MM simulations. J Chem Theory Comput 15:5794\u20135809","journal-title":"J Chem Theory Comput"},{"key":"6634_CR53","doi-asserted-by":"publisher","first-page":"4092","DOI":"10.1021\/cr800551w","volume":"109","author":"HX Zhou","year":"2009","unstructured":"Zhou HX, Gilson MK (2009) Theory of free energy and entropy in noncovalent binding. Chem Rev 109:4092\u20134107","journal-title":"Chem Rev"},{"key":"6634_CR54","unstructured":"Flomenberg P, Daniel R (2019) Overview of gene therapy, gene editing, and gene silencing. Waltham, MA"},{"key":"6634_CR55","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1002\/cbin.10694","volume":"40","author":"ES \u00c7a\u011flayan","year":"2016","unstructured":"\u00c7a\u011flayan ES (2016) Generation of improved human cerebral organoids from single copy DYRK1A knockout induced pluripotent stem cells in trisomy 21: hypothetical solutions for neurodevelopmental models and therapeutic alternatives in down syndrome. Cell Biol Int 40:1256\u20131270. https:\/\/doi.org\/10.1002\/cbin.10694","journal-title":"Cell Biol Int"},{"key":"6634_CR56","doi-asserted-by":"publisher","first-page":"994","DOI":"10.33594\/000000283","volume":"54","author":"S Valentina","year":"2020","unstructured":"Valentina S, Sergiu P, Ancuta J (2020) Microrna-155-5p plays a critical role in transient leukemia of down syndrome by targeting tumor necrosis factor receptor superfamily members. Cell Physiol Biochem 54:994\u20131012. https:\/\/doi.org\/10.33594\/000000283","journal-title":"Cell Physiol Biochem"}],"container-title":["Journal of Molecular Modeling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-026-06634-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00894-026-06634-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-026-06634-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T09:34:21Z","timestamp":1770802461000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00894-026-06634-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["6634"],"URL":"https:\/\/doi.org\/10.1007\/s00894-026-06634-6","relation":{},"ISSN":["1610-2940","0948-5023"],"issn-type":[{"value":"1610-2940","type":"print"},{"value":"0948-5023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"18 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}